Literature DB >> 12895181

Ciclopirox for the treatment of superficial fungal infections: a review.

Aditya K Gupta1, Alayne R Skinner.   

Abstract

Ciclopirox is a broad-spectrum antifungal agent that also exhibits anti-inflammatory and antibacterial activity. The lotion and cream formulations of ciclopirox are effective in many types of infection, including tinea corporis/cruris, tinea pedis, cutaneous candidiasis, pityriasis (tinea) versicolor, and seborrheic dermatitis. The new ciclopirox gel 0.77% formulation is also indicated for the treatment of seborrheic dermatitis of the scalp, interdigital tinea pedis and tinea corporis.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12895181     DOI： 10.1046/j.1365-4362.42.s1.2.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


  10 in total

1.  Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.

Authors:  Suélen Andreia Rossi; Haroldo Cesar de Oliveira; Daniel Agreda-Mellon; José Lucio; Maria José Soares Mendes-Giannini; Jesús Pablo García-Cambero; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

Review 2.  Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.

Authors:  Alessandro Subissi; Daniela Monti; Giuseppe Togni; Federico Mailland
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

3.  Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains.

Authors:  Giovanni Di Bonaventura; Veronica Lupetti; Simone De Fabritiis; Alessandra Piccirilli; Annamaria Porreca; Marta Di Nicola; Arianna Pompilio
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

4.  Evaluation of the Efficacy of ME1111 in the Topical Treatment of Dermatophytosis in a Guinea Pig Model.

Authors:  L Long; C Hager; M Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

5.  Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus.

Authors:  Kol A Zarember; Anna R Cruz; Chiung-Yu Huang; John I Gallin
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

6.  Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway.

Authors:  Hongyu Zhou; Tao Shen; Chaowei Shang; Yan Luo; Lei Liu; Juming Yan; Yan Li; Shile Huang
Journal:  Oncotarget       Date:  2014-10-30

7.  Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris.

Authors:  Haroldo Cesar de Oliveira; Maria Candida Monteiro; Suélen Andreia Rossi; Javier Pemán; Alba Ruiz-Gaitán; Maria José Soares Mendes-Giannini; Emilia Mellado; Oscar Zaragoza
Journal:  Front Cell Infect Microbiol       Date:  2019-04-02       Impact factor: 5.293

8.  Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling.

Authors:  Zhipeng Su; Shengnan Han; Qiumei Jin; Ningning Zhou; Junwan Lu; Fugen Shangguan; Shiyi Yu; Yongzhang Liu; Lu Wang; Jianglong Lu; Qun Li; Lin Cai; Chengde Wang; Xiaohe Tian; Lingyan Chen; Weiming Zheng; Bin Lu
Journal:  Cell Death Dis       Date:  2021-03-05       Impact factor: 8.469

9.  Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development.

Authors:  Gina Wall; Ashok K Chaturvedi; Floyd L Wormley; Nathan P Wiederhold; Hoja P Patterson; Thomas F Patterson; José L Lopez-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

10.  Two New Compounds Containing Pyridinone or Triazine Heterocycles Have Antifungal Properties against Candida albicans.

Authors:  Laura Mena; Muriel Billamboz; Rogatien Charlet; Bérangère Desprès; Boualem Sendid; Alina Ghinet; Samir Jawhara
Journal:  Antibiotics (Basel)       Date:  2022-01-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.